Clinicians have been centrally important to the success of ESTRO and have served at the highest level on the Society’s Board, Education & Training Committee and other committees together with a wide range of ad hoc groups advising on many issues ranging from the very successful annual scientific meetings to the expanding spectrum of teaching courses.

Recognising the wide range of special and occasionally unique issues that are increasingly important to clinicians, the ESTRO Board decided to appoint the first Clinical Committee in 2007.

The committee endeavours to explore a wide range of existing day to day issues together with emerging strategic issues relevant to radiation oncologists as members of the Society. The critical role of research and the development of mechanisms that enable and support evidence-based multidisciplinary treatment approaches for patients and their families are central to the committee’s thinking and strategic goals.  Since its inception, the committee has initiated wide-ranging discussions on a number of major thematic areas of interest to ESTRO clinicians together with areas of potential concern or uncertainty. 

Chair: Karin Haustermans, Leuven, Belgium

Young Committee Observer: Martin-Immanuel Bittner, Cambridge, United Kingdom

Eric Deutsch, Villejuif, Paris, France

Corinne Faivre-Finn, Manchester, UK

Dorota Gabrys, Gliwice, Poland

Antonietta​ Gambacorta, Rome, Italy

Peter Hoskin, Northwood, United Kingdom

Florence Huguet, Paris, France

Hans Langendijk, Groningen, The Netherlands

Pedro Lara, Las Palmas de Gran Canaria, Spain

Lorenzo Livi, Florence, Italy

Marianne Nordsmark, Aarhus, Denmark

Esther Troost, Dresden, Germany

The committee is contactable through Eralda Azizaj at the ESTRO office.